News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ERYtech Pharma Gives Feedback On Its First Investor R&D Day And Provides A Financial And Business Update For Q4 2013



1/28/2014 8:02:05 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Regulatory News:

ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, held its first Investor R&D day and provides a financial and business update for the fourth quarter of 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES